Home > Journals > Italian Journal of Vascular and Endovascular Surgery > Past Issues > Italian Journal of Vascular and Endovascular Surgery 2008 September;15(3) > Italian Journal of Vascular and Endovascular Surgery 2008 September;15(3):171-8

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

ITALIAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

A Journal on Vascular and Endovascular Surgery


Official Journal of the Italian Society of Vascular and Endovascular Surgery
Indexed/Abstracted in: EMBASE, Emerging Sources Citation Index, Scopus


eTOC

 

REVIEWS  


Italian Journal of Vascular and Endovascular Surgery 2008 September;15(3):171-8

Copyright © 2008 EDIZIONI MINERVA MEDICA

language: English

In-stent restenosis after carotid angioplasty and stenting

Setacci C., de Donato G., Chisci E., Setacci F., Sirignano P., Galzerano G., Cappelli A., Palasciano G.

Department of Vascular and Endovascular Surgery University of Siena, Siena, Italy


PDF  


Carotid artery stenting (CAS) is a viable alternative to carotid endarterectomy (CEA) in selected patients with a severe carotid stenosis. Long-term patency following CAS can be limited by restenosis due to neointimal hyperplasia or recurrent atherosclerosis. CAS patients require intensive follow-up to monitor the patency of the device and the potential development of an in-stent restenosis (ISR), which continues to be the “Achilles’ heel” of any catheter intervention.ISR after CAS is now considered to have a lower incidence in comparison to other vascular distrticts. The literature reported a progressive reduction of the incidence of carotid ISR by the years, from 15% to the actual 1-3%/year. Long-term results in several published cohort of patients in literature seems to validate CAS as a durable procedure for stroke prevention. The ISR rate appears to be acceptable, and the need for reintervention is low. There are several putative causes of re-stenosis after CAS, but the literature is not conclusive about true predictors of ISR.A rigorous duplex ultrasound follow-up of CAS with corrected velocity criteria is mandatory to early recognize any kind of late complications. In-stent restenotic carotid lesions may be safely treated by further percutaneous interventions.

top of page

Publication History

Cite this article as

Corresponding author e-mail